DK62286A - Ikke-antibakterielle tetracyclinpraeparater med anticollagenolytiske egenskaber - Google Patents

Ikke-antibakterielle tetracyclinpraeparater med anticollagenolytiske egenskaber Download PDF

Info

Publication number
DK62286A
DK62286A DK62286A DK62286A DK62286A DK 62286 A DK62286 A DK 62286A DK 62286 A DK62286 A DK 62286A DK 62286 A DK62286 A DK 62286A DK 62286 A DK62286 A DK 62286A
Authority
DK
Denmark
Prior art keywords
tetracyclines
anticollagenolytic
properties
compositions containing
same
Prior art date
Application number
DK62286A
Other languages
English (en)
Other versions
DK62286D0 (da
DK174997B1 (da
Inventor
Thomas F Mcnamara
Nungavaram S Ramamurthy
Lorne M Golub
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of DK62286D0 publication Critical patent/DK62286D0/da
Publication of DK62286A publication Critical patent/DK62286A/da
Application granted granted Critical
Publication of DK174997B1 publication Critical patent/DK174997B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK198600622A 1985-02-07 1986-02-07 Ikke-antibakterielle tetracyclinpræparater med anticollagennolytiske egenskaber DK174997B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69904885 1985-02-07
US06/699,048 US4704383A (en) 1983-12-29 1985-02-07 Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same

Publications (3)

Publication Number Publication Date
DK62286D0 DK62286D0 (da) 1986-02-07
DK62286A true DK62286A (da) 1986-08-08
DK174997B1 DK174997B1 (da) 2004-04-13

Family

ID=24807719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198600622A DK174997B1 (da) 1985-02-07 1986-02-07 Ikke-antibakterielle tetracyclinpræparater med anticollagennolytiske egenskaber

Country Status (12)

Country Link
US (1) US4704383A (da)
EP (1) EP0195906B1 (da)
JP (1) JP2676080B2 (da)
AT (1) ATE81460T1 (da)
AU (1) AU583884B2 (da)
CA (1) CA1297410C (da)
DE (1) DE3686956T2 (da)
DK (1) DK174997B1 (da)
ES (1) ES8708182A1 (da)
GR (1) GR860333B (da)
IE (1) IE58813B1 (da)
ZA (1) ZA86838B (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34656E (en) * 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
GR861167B (en) * 1985-05-02 1986-09-30 Research Corp Bone targeted inhibitors of carbonic anhydrase
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5045538A (en) * 1990-06-28 1991-09-03 The Research Foundation Of State University Of New York Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
WO1992012717A2 (en) * 1991-01-15 1992-08-06 A composition containing a tetracycline and use for inhibiting angiogenesis
US5770588A (en) * 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US5223248A (en) * 1991-02-11 1993-06-29 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing antiplaque properties
CA2094874C (en) * 1992-04-27 2003-02-11 Thomas F. Mcnamara Non-antibacterial tetracycline compositons possessing antiplaque properties
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
ES2170074T3 (es) * 1992-09-10 2002-08-01 Childrens Medical Center Matrices de polimero biodegradables para la liberacion prolongada de agentes anestesicos locales.
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US6043231A (en) * 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
US6140099A (en) * 1994-05-20 2000-10-31 The Trustees Of The University Of Pennsylvania Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
CA2195119C (en) 1995-06-09 2001-09-11 Mark Chasin Formulations and methods for providing prolonged local anesthesia
EP0954301A4 (en) 1996-06-24 2006-03-08 Euro Celtique Sa SAFE METHODS OF LOCAL ANESTHESIA
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
JP2908375B2 (ja) 1997-04-01 1999-06-21 ザ リサーチ ファンデーション オブ ステート ユニバーシティ オブ ニューヨーク 非抗バクテリア性テトラサイクリン組成物
KR100367144B1 (ko) 1997-07-02 2003-01-14 유로-셀티크 소시에떼 아노뉨 관절과 체강(body space)내에서 연장된 마취
JP2001513559A (ja) 1997-08-25 2001-09-04 ブレム,ハロルド 新脈管形成インヒビターを用いる癒着および過剰な瘢痕形成の予防
CA2316972C (en) * 1997-12-19 2009-02-24 New York University Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
PT1053000E (pt) * 1998-02-13 2008-07-11 Nutramax Lab Inc Agentes e métodos para protecção, tratamento e reparação do tecido conjuntivo
US6277061B1 (en) * 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
KR20010043820A (ko) * 1998-05-27 2001-05-25 유로셀띠끄 소시에떼 아노님 치밀하게 컴팩트된 고체약물스톡을 포함하는 약물전달시스템
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US6946453B2 (en) 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6294694B1 (en) 1999-06-04 2001-09-25 Wisconsin Alumni Research Foundation Matrix metalloproteinase inhibitors and method of using same
US6673843B2 (en) 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis
US20020132798A1 (en) 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP2311440A1 (en) 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
WO2003005971A2 (en) 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
US7214669B2 (en) * 2001-10-05 2007-05-08 Tetragenex Pharmaceuticals, Inc. Tetracycline derivatives and methods of use thereof
EP1474380A4 (en) 2002-01-08 2007-04-18 Paratek Pharm Innc 4-DESDIMETHYL AMINO TETRA CYCLINE COMPOUNDS
EA200802365A1 (ru) 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
US20090011991A1 (en) * 2002-03-08 2009-01-08 Emory University Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
CA2478522A1 (en) * 2002-03-08 2003-09-18 Emory University Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
EP1503981A4 (en) 2002-03-21 2007-08-15 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS
KR20040094833A (ko) 2002-03-29 2004-11-10 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 비-항균성 테트라사이클린 동족체의 용도 및 박테리아외독소의 치료를 위한 이의 제형
EP1534300A4 (en) 2002-07-12 2008-04-23 Paratek Pharm Innc TETRACYCLINE COMPOUNDS SUBSTITUTED IN 3, 10, AND 12A
WO2004054509A2 (en) * 2002-12-13 2004-07-01 The Research Foundation Of State University Of New York Tetracyclines as anti-fungal agents for treatment of ringworm
ES2391385T3 (es) 2003-04-07 2012-11-23 Supernus Pharmaceuticals, Inc. Formulaciones de doxiciclinas en dosis única diaria
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4733028B2 (ja) 2003-07-09 2011-07-27 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
EP1716101A1 (en) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
EP2949644A3 (en) 2004-10-25 2016-04-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
BRPI0602372B8 (pt) 2006-05-18 2021-06-22 Einco Biomaterial Ltda processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado
MX2009006846A (es) 2006-12-21 2009-08-20 Paratek Pharm Innc Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
CA2892739A1 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2010525069A (ja) 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
CN101784517A (zh) * 2007-07-06 2010-07-21 帕拉特克药品公司 合成取代的四环素化合物的方法
TW202021946A (zh) * 2008-05-23 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
KR101856178B1 (ko) 2008-08-08 2018-05-10 테트라페이즈 파마슈티컬스, 인코포레이티드 C7-플루오로 치환된 테트라시클린 화합물
WO2010129057A2 (en) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
NO2470500T3 (da) 2009-08-28 2018-03-03
TWI592390B (zh) 2010-03-31 2017-07-21 四相製藥公司 聚環狀四環素化合物
KR101953736B1 (ko) * 2012-05-21 2019-03-04 디씨비-유에스에이 엘엘씨 제브라피시 모델을 사용한 약물 스크리닝 방법 및 이 방법으로 스크린된 화합물
BR112015004523B1 (pt) 2012-08-31 2020-08-04 Tetraphase Pharmaceuticals, Inc Compostos de tetraciclina, composições farmacêuticas e seus usos
SG11201903327PA (en) 2016-10-19 2019-05-30 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB787882A (en) * 1955-01-26 1957-12-18 Lepetit Spa Desdimethylaminotetracyclines and pharmaceutical preparations containing same
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
GB925282A (en) * 1960-05-04 1963-05-08 Lepetit Spa Fermentation process for the production of demethyltetracycline
US3304227A (en) * 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
US3636202A (en) * 1968-02-12 1972-01-18 Lewis A Klein Treatment of rheumatoid arthritis and related diseases
US4371465A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity

Also Published As

Publication number Publication date
DK62286D0 (da) 1986-02-07
AU583884B2 (en) 1989-05-11
EP0195906B1 (en) 1992-10-14
EP0195906A3 (en) 1988-10-19
DK174997B1 (da) 2004-04-13
ZA86838B (en) 1986-10-29
EP0195906A2 (en) 1986-10-01
CA1297410C (en) 1992-03-17
JPS61243023A (ja) 1986-10-29
DE3686956T2 (de) 1993-05-06
GR860333B (en) 1986-06-13
JP2676080B2 (ja) 1997-11-12
US4704383A (en) 1987-11-03
DE3686956D1 (de) 1992-11-19
ES8708182A1 (es) 1987-10-01
AU5298486A (en) 1986-08-14
IE860333L (en) 1986-08-07
IE58813B1 (en) 1993-11-17
ES551701A0 (es) 1987-10-01
ATE81460T1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
DK62286A (da) Ikke-antibakterielle tetracyclinpraeparater med anticollagenolytiske egenskaber
KR0145958B1 (en) Antibacterial agents
ZA899353B (en) Novel polymeric quaternary ammonium trihalides and use of polymeric quaternary ammonium trihalides as microbicides,sanitizers and disinfectants
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
ATE152734T1 (de) Bpc-peptide, deren herstellung und verwendung
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
HU9203550D0 (en) Shaped bodies amde of block-polymerized thermoplastic polyether and their manufacturing method
DE3872063D1 (de) Zusammensetzung mit anregender wirkung fuer die haare.
DE3885394D1 (de) Teicoplaninähnliche Derivate.
IT1240683B (it) Composizione farmaceutica contenente egf
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HUT64093A (en) Shaped bodies comprising thermoplastic copolyester-based active ingredient and process for producing same
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ES2058057T3 (es) Derivados de lancacidina y su produccion.
EP0211490A3 (en) Antibiotics of the vancomycin-class
CA2122780A1 (fr) Utilisation de la selegiline en medecine veterinaire
GR3004095T3 (da)
ZA871140B (en) Synergistic chemical compositions for treating salmonellosis
MY101875A (en) Lankacidin derivatives and production thereof.
ATE206617T1 (de) Verwendung von escherichia coli stamm dsm 6601 zur behandlung von diarrhoeen auf dem veterinärsektor
DE68907163D1 (de) Antiepileptisch wirkende pyrazolopyridine.
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.

Legal Events

Date Code Title Description
PUP Patent expired